The Medical Letter on Drugs and Therapeutics
Mometasone/Formoterol (Dulera) for Asthma
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Revised 10/26/10: In the Clinical Studies section, the second clinical trial compared the 2 different strengths of the combinations with mometasone alone, 400 mcg twice daily, and not with placebo.

A combination of the corticosteroid mometasone furoate (Asmanex) and the long-acting beta2-agonist (LABA) formoterol (Foradil) has become available in a single metered-dose inhaler (Dulera – Schering) for treatment of asthma in patients ≥12 years old. It is the third corticosteroid/LABA combination inhaler to become available for this indication in the US. None of these combinations should be used for initial treatment of asthma or for acute treatment of asthma symptoms.

STANDARD TREATMENT — Persistent asthma can be controlled in most patients with regular use of an inhaled corticosteroid in addition to as-needed use of an inhaled short-acting beta2-agonist for acute exacerbations. When twice-daily use of an inhaled corticosteroid alone does not prevent symptoms, addition of an inhaled LABA is generally considered more effective and safer than increasing the ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Mometasone Formoterol (Dulera) for Asthma
Article code: 1349c
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian